We showed that the germline p.Ile171Val mutation in NBN, one of the M/R/N genes, may be considered a risk factor in the development of solid malignant tumors, including breast cancer, larynx and colorectal cancer or acute lymphoblastic leukemia (ALL) [14–17]. This evidence concerns the gene NBN and breast cancer.